Evidence map›Paper›PMID 30024803›Full record

ArticleAmerican journal of public health2018

Human Papillomavirus Vaccine Initiation for Adolescents Following Rhode Island's School-Entry Requirement, 2010-2016.

Erika L Thompson, Melvin D Livingston, Ellen M Daley, Gregory D Zimet

Abstract read
In one paragraph

Article in American journal of public health, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Erika L ThompsonErika L. Thompson is with the Department of Health Behavior & Health Systems, School of Public Health, University of North Texas Health Science Center, Fort Worth. Melvin D. Livingston III, is with the Department of Biostatistics and Epidemiology, School of Public Health, University of North Texas Health Science Center. Ellen M. Daley is with the Department of Community and Family Health, College of Public Health, University of South Florida, Tampa. Gregory D. Zimet is with the Department of Pediatrics, Indiana University School of Medicine, Indianapolis.
Melvin D LivingstonErika L. Thompson is with the Department of Health Behavior & Health Systems, School of Public Health, University of North Texas Health Science Center, Fort Worth. Melvin D. Livingston III, is with the Department of Biostatistics and Epidemiology, School of Public Health, University of North Texas Health Science Center. Ellen M. Daley is with the Department of Community and Family Health, College of Public Health, University of South Florida, Tampa. Gregory D. Zimet is with the Department of Pediatrics, Indiana University School of Medicine, Indianapolis.
Ellen M DaleyErika L. Thompson is with the Department of Health Behavior & Health Systems, School of Public Health, University of North Texas Health Science Center, Fort Worth. Melvin D. Livingston III, is with the Department of Biostatistics and Epidemiology, School of Public Health, University of North Texas Health Science Center. Ellen M. Daley is with the Department of Community and Family Health, College of Public Health, University of South Florida, Tampa. Gregory D. Zimet is with the Department of Pediatrics, Indiana University School of Medicine, Indianapolis.
Gregory D ZimetErika L. Thompson is with the Department of Health Behavior & Health Systems, School of Public Health, University of North Texas Health Science Center, Fort Worth. Melvin D. Livingston III, is with the Department of Biostatistics and Epidemiology, School of Public Health, University of North Texas Health Science Center. Ellen M. Daley is with the Department of Community and Family Health, College of Public Health, University of South Florida, Tampa. Gregory D. Zimet is with the Department of Pediatrics, Indiana University School of Medicine, Indianapolis.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo assess changes in human papillomavirus (HPV) vaccine initiation for adolescent girls and boys in Rhode Island compared with all other states.

methodsWe estimated the gender-specific effects of Rhode Island's school-entry HPV vaccination policy on self-reported HPV vaccination initiation by using a difference-in-differences design with the National Immunization Survey-Teen from 2010 through 2016.

resultsCompared with boys in other states, boys in Rhode Island increased their HPV vaccine initiation rate by 11% (b = 0.11; 95% confidence interval [CI] = 0.05, 0.18) after enactment of the requirement. No difference was seen in the probability of HPV vaccine initiation among girls in Rhode Island compared with girls in the multistate control (b = -0.01; 95% CI = -0.08, 0.05).

conclusionsOur analysis identified an 11% increase in HPV vaccine initiation rate among boys in Rhode Island after the school-entry requirement was enacted, whereas no significant change was observed for girls. Public Health Implications. Given suboptimal vaccine uptake rates in the United States, continued pursuit of state-level public policy to improve HPV vaccination is needed. School-entry requirements for HPV vaccination may be a strategy for closing the gap in HPV vaccine uptake for boys and girls.

Indexed as

Public PolicySchoolsAdolescentFemaleHumansMalePapillomavirus InfectionsPapillomavirus VaccinesPatient Acceptance of Health CareRhode IslandUnited StatesPapillomavirus Vaccines

Identifiers

PMID30024803
PMCPMC6137780

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.